Purpose: Based on recovered metabolite ratios in urine, it has been concluded that paracetamol glucuronidation may be up-regulated upon multiple dosing. This study investigates paracetamol clearance in neonates and infants after single and multiple dosing using a population modelling approach. Methods: A population pharmacokinetic model was developed in NONMEM VI, based on paracetamol plasma concentrations from 54 preterm and term neonates and infants, and on paracetamol, paracetamol-glucuronide and paracetamol-sulphate amounts in urine from 22 of these patients. Patients received either a single intravenous propacetamol dose or up to 12 repeated doses. Results: Paracetamol and metabolite disposition was best described with one-compartment ...
AIM: A recent report on intravenous (i.v.) paracetamol pharmacokinetics (PK) showed a higher total c...
OBJECTIVES: We suggested a loading dose (20 mg · kg(-1) ) followed by 10 mg · kg(-1) q6h of intraven...
Background: We previously showed the practical and ethical feasibility of using [14C]-microdosing fo...
PURPOSE: Based on recovered metabolite ratios in urine, it has been concluded that paracetamol glucu...
AimThe therapeutic options available to treat neonatal pain are limited, and one alternative for non...
OBJECTIVES: This study aimed to model the population pharmacokinetics of intravenous paracetamol and...
In order to characterize the variation in pharmacokinetics of paracetamol across the human age span,...
OBJECTIVES: The aims of this study were to develop a population pharmacokinetic model for intravenou...
In order to characterize the variation in pharmacokinetics of paracetamol across the human age span,...
Objectives The aims of this study were to develop a population pharmacokinetic model for intravenous...
Aims To investigate the pharmacokinetics and safety of prolonged paracetamol use (\u3e72 h) for neo...
Paracetamol is commonly used to control mild-to-moderate pain or to reduce opioid exposure as part o...
Paracetamol is commonly used to control mild-to-moderate pain or to reduce opioid exposure as part o...
Paracetamol (acetaminophen) is commonly used to manage mild and moderate pain in neonates 1. There h...
AIM: A recent report on intravenous (i.v.) paracetamol pharmacokinetics (PK) showed a higher total c...
OBJECTIVES: We suggested a loading dose (20 mg · kg(-1) ) followed by 10 mg · kg(-1) q6h of intraven...
Background: We previously showed the practical and ethical feasibility of using [14C]-microdosing fo...
PURPOSE: Based on recovered metabolite ratios in urine, it has been concluded that paracetamol glucu...
AimThe therapeutic options available to treat neonatal pain are limited, and one alternative for non...
OBJECTIVES: This study aimed to model the population pharmacokinetics of intravenous paracetamol and...
In order to characterize the variation in pharmacokinetics of paracetamol across the human age span,...
OBJECTIVES: The aims of this study were to develop a population pharmacokinetic model for intravenou...
In order to characterize the variation in pharmacokinetics of paracetamol across the human age span,...
Objectives The aims of this study were to develop a population pharmacokinetic model for intravenous...
Aims To investigate the pharmacokinetics and safety of prolonged paracetamol use (\u3e72 h) for neo...
Paracetamol is commonly used to control mild-to-moderate pain or to reduce opioid exposure as part o...
Paracetamol is commonly used to control mild-to-moderate pain or to reduce opioid exposure as part o...
Paracetamol (acetaminophen) is commonly used to manage mild and moderate pain in neonates 1. There h...
AIM: A recent report on intravenous (i.v.) paracetamol pharmacokinetics (PK) showed a higher total c...
OBJECTIVES: We suggested a loading dose (20 mg · kg(-1) ) followed by 10 mg · kg(-1) q6h of intraven...
Background: We previously showed the practical and ethical feasibility of using [14C]-microdosing fo...